|Articles|May 1, 2003
Ms.Codit
Author(s)Inga Ellzey
Q: It is not a common practice, but there are certain situations when a patient has a very ill-defined skin cancer. Since I am not a Mohs surgeon, I must rely on a local laboratory for my pathology services. When I am uncomfortable with the excision, meaning that I am unsure whether all the margins will be clear, I don't want to spend an hour or so doing a flap or a graft only to have to tear it out if I get a pathology report back with a dirty margin.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Christopher Bunick, MD, PhD, on Expanding Targets in Inflammatory Skin Disease
2
When Innovation Meets Insurance Barriers With Lisa Swanson, MD
3
Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD
4
GLP-1s and Skin Health: Clinical Pearls From Gold and Lal
5






